Anika Therapeutics reported $94.6M in Cash and Equivalent for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 455.51M 215.44M
Acorda Therapeutics ACOR:US $ 116.77M 45.4M
Adamas Pharmaceuticals ADMS:US 71.66M 20.86M
Agenus AGEN:US $ 119.37M 19.5M
Agios Pharmaceuticals AGIO:US $ 1888.02M 1760.59M
Anika Therapeutics ANIK:US $ 94.6M 1.22M
Arrowhead Research ARWR:US $ 372.38M 232.46M
Chemocentryx CCXI:US $ 424.16M 391.86M
Clovis Oncology CLVS:US $ 190.92M 49.31M
Dicerna Pharmaceuticals DRNA:US $ 159.11M 33.09M
Enanta Pharmaceuticals ENTA:US $ 77.13M 22.03M
Halozyme Therapeutics HALO:US $ 147.7M 81.96M
Heron Therapeutics HRTX:US $ 59.74M 45.4M
Immunogen IMGN:US $ 293.86M 105.64M
Insmed INSM:US $ 409.75M 123M
Integra Lifesciences IART:US $ 408.98M 61.19M
Johnson & Johnson JNJ:US $ 2094M 8M
Karyopharm Therapeutics KPTI:US $ 88.47M 2.55M
Ligand Pharmaceuticals LGND:US $ 339.21M 291.59M
Macrogenics MGNX:US $ 218.5M 37.36M
Merit Medical Systems MMSI:US $ 58.52M 1.6M
Rigel Pharmaceuticals RIGL:US $ 20.05M 10.33M
Sangamo Biosciences SGMO:US $ 122.98M 8.35M
Stryker SYK:US $ 2238M 705M
Surmodics SRDX:US $ 48.16M 12.4M
Veracyte VCYT:US $ 349.36M 4.28M
Xencor XNCR:US $ 176.96M 13.42M
Zimmer Biomet Holdings Inc ZBH:US $ 724.3M 77.8M